000 | 01281 a2200265 4500 | ||
---|---|---|---|
005 | 20250517123426.0 | ||
264 | 0 | _c20180301 | |
008 | 201803s 0 0 eng d | ||
022 | _a1873-2496 | ||
024 | 7 |
_a10.1016/j.urolonc.2016.02.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLin, Daniel | |
245 | 0 | 0 |
_aCommentary on "RNA biomarkers associated with metastatic progression in prostate cancer: A multi-institutional high-throughput analysis of SChLAP1." Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A, Siddiqui J, Davicioni E, Den RB, Dicker AP, Karnes RJ, Wei JT, Klein EA, Jenkins RB, Chinnaiyan AM, Feng FY, University of Washington-Urology, Seattle, WA. Lancet Oncol 2014; 15(13):1469-80. _h[electronic resource] |
260 |
_bUrologic oncology _c11 2016 |
||
300 |
_a521-522 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
650 | 0 | 4 |
_aRNA, Long Noncoding _xgenetics |
773 | 0 |
_tUrologic oncology _gvol. 34 _gno. 11 _gp. 521-522 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urolonc.2016.02.006 _zAvailable from publisher's website |
999 |
_c26578362 _d26578362 |